These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34151807)

  • 1. Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.
    Pilotto A; Imarisio A; Carrarini C; Russo M; Masciocchi S; Gipponi S; Cottini E; Aarsland D; Zetterberg H; Ashton NJ; Hye A; Bonanni L; Padovani A
    J Alzheimers Dis; 2021; 82(3):913-919. PubMed ID: 34151807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodromal dementia with Lewy bodies.
    Donaghy PC; O'Brien JT; Thomas AJ
    Psychol Med; 2015 Jan; 45(2):259-68. PubMed ID: 25066469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neurofilament light chain levels in Alzheimer's disease.
    Zhou W; Zhang J; Ye F; Xu G; Su H; Su Y; Zhang X;
    Neurosci Lett; 2017 May; 650():60-64. PubMed ID: 28428015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
    Alcolea D; Delaby C; Muñoz L; Torres S; Estellés T; Zhu N; Barroeta I; Carmona-Iragui M; Illán-Gala I; Santos-Santos MÁ; Altuna M; Sala I; Sánchez-Saudinós MB; Videla L; Valldeneu S; Subirana A; Pegueroles J; Hirtz C; Vialaret J; Lehmann S; Karikari TK; Ashton NJ; Blennow K; Zetterberg H; Belbin O; Blesa R; Clarimón J; Fortea J; Lleó A
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1206-1214. PubMed ID: 34103344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentations and diagnostic application of proposed biomarkers in psychiatric-onset prodromal dementia with Lewy bodies.
    Kobayashi R; Iwata-Endo K; Fujishiro H
    Psychogeriatrics; 2024 Jul; 24(4):1004-1022. PubMed ID: 38837629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
    Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
    Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies.
    Cagnin A; Bussè C; Jelcic N; Gnoato F; Mitolo M; Caffarra P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):303-5. PubMed ID: 25547859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterization of mild cognitive impairment as a prodrome to dementia with Lewy bodies.
    Belden CM; Kahlon V; Malek-Ahmadi M; Tsai A; Sabbagh MN
    Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):173-7. PubMed ID: 25013117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset.
    Wyman-Chick KA; O'Keefe LR; Weintraub D; Armstrong MJ; Rosenbloom M; Martin PK; Barclay TR; Barrett MJ
    J Geriatr Psychiatry Neurol; 2022 Jul; 35(4):527-534. PubMed ID: 34114509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
    Sugarman MA; Zetterberg H; Blennow K; Tripodis Y; McKee AC; Stein TD; Martin B; Palmisano JN; Steinberg EG; Simkin I; Budson AE; Killiany R; O'Connor MK; Au R; Qiu WWQ; Goldstein LE; Kowall NW; Mez J; Stern RA; Alosco ML
    Neurobiol Aging; 2020 Oct; 94():60-70. PubMed ID: 32585491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic Features Among Patients in the Prodromal Stage of Dementia with Lewy Bodies During Longitudinal Observation.
    Utsumi K; Fukatsu R; Hara Y; Takamaru Y; Yasumura S
    J Alzheimers Dis; 2021; 83(4):1917-1927. PubMed ID: 34459395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    Gan J; Liu S; Chen Z; Yang Y; Ma L; Meng Q; Wang XD; Liu C; Li X; Zhang W; Ji Y
    J Alzheimers Dis; 2022 Jun; 88(3):1037-1048. PubMed ID: 35723094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.
    Naude JP; Gill S; Hu S; McGirr A; Forkert ND; Monchi O; Stys PK; Smith EE; Ismail Z;
    J Alzheimers Dis; 2020; 76(3):1017-1027. PubMed ID: 32597801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?
    Blanc F; Verny M
    Geriatr Psychol Neuropsychiatr Vieil; 2017 Jun; 15(2):196-204. PubMed ID: 28625940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodromal dementia with Lewy bodies.
    Fujishiro H; Nakamura S; Sato K; Iseki E
    Geriatr Gerontol Int; 2015 Jul; 15(7):817-26. PubMed ID: 25690399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.